Stop meddling with Medicare

As many as 36 million Americans narrowly dodged a recent proposal from the Centers for Medicare and Medicaid Services (CMS) that would have advanced unprecedented government intrusion within the Medicare Part D prescription drug program.

CMS never offered a satisfactory reason for its proposed tinkering with something that's working. Part D is a real rarity -- a genuinely popular and cost-effective federal health program. The proposed reforms were not only unnecessary; they would have compromised affordability, limited treatment options for patients, and stifled innovation in the insurance industry.

Though the misguided proposal has been shelved, Part D is still at risk. The Obama administration has pledged to push through a similar plan in the near future.

By all accounts, Medicare Part D is overwhelmingly successful. The program offers drug coverage to seniors for a monthly average of $31 and enjoys a 90 percent approval rating among beneficiaries.
 
Sign Up for Our Email Newsletter

RECENT NEWS

How Other Countries Freeload on U.S. Drug Research

How Other Countries Freeload on U.S. Drug Research

Letting Americans buy prescriptions from foreign retailers would impair the development of new cures....  Read more

Reduce drug prices by eliminating PBM rebates

Reduce drug prices by eliminating PBM rebates

Unless we end the rigged system of rebates, insurers, PBMs and drug companies will find themselves threatened with more g...  Read more

The Privacy Delusions Of Genetic Testing

The Privacy Delusions Of Genetic Testing

Genetic-testing companies cannot guarantee privacy. And many are actively selling user data to outside parties....  Read more

DRUGWONKS BLOG